October Newsletter features Zephyr Sleep CEO interview, FDA Updates

Ever wonder why we’re called StarFish?  Check out Scott’s video for the key “points” in our October Newsletter.

Plus:

  • Paul Cataford, Zephyr Sleep Technologies CEO, talks about the North American roll-out of MATRx™ – the company’s Medical Device for determining whether oral appliance therapy will treat Obstructive Sleep Apnea
  • FDA impacted by US Budget shutdown
  • StarFish Medical’s Director of Quality/Regulatory, Vesna Janic comments on recent FDA Guidances
  • Vincent Crabtree provides insight on:  FDA issues final guidance on mobile medical apps, New rapid blood test can differentiate between bacterial and viral infections, and Phonebloks: The smartphone for the rest of your life.
Share on Facebook0Share on LinkedIn0Tweet about this on Twitter